Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Perspectives and experiences of Dutch multiple sclerosis patients and multiple sclerosis-specialized neurologists on injectable disease-modifying treatment.
Association between the IL7R T244I polymorphism and multiple sclerosis risk: a meta analysis.
Clinical utility and psychometric properties of the Functional Assessment of Multiple Sclerosis for individuals with multiple sclerosis.
Primary progressive multiple sclerosis-why we are failing.
Andiamo! Moving forward with autologous hematopoietic transplantation for highly active MS
Malignancies after mitoxantrone for multiple sclerosis: A retrospective cohort study.
Improving the translational hit of experimental treatments in multiple sclerosis.
Characteristics of Patients with Relapsing Remitting Multiple Sclerosis Taking Injectable and Oral Disease Modifying Treatments in the United States.
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.
Anti-myelin Oligodendrocyte Glycoprotein Antibodies in a Patient with Recurrent Optic Neuritis Involving the Cerebral White Matter and Brainstem.
Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis.
Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour?
Biochemical manifestations of the nervous tissue degradation after the blood-brain barrier opening or water intoxication in rats.
EAE: an immunologist's magic eye.
Brain MRI results of DECIDE: a randomized, double-blind trial of DAC HYP vs. IFNβ-1a in RRMS patients
Pregnancy outcomes in Lebanese women with multiple sclerosis (the LeMS study): a prospective multicentre study.
Central Pontine and Extrapontine Myelinolysis in a Patient with Traumatic Brain Injury Following Not Rapid Correction of Hyponatremia: A Case Report.
Quantitative Susceptibility Mapping Indicates a Disturbed Brain Iron Homeostasis in Neuromyelitis Optica - A Pilot Study.
USPTO list of patent term extensions
Leptomeningeal enhancement in Susac's syndrome and multiple sclerosis: Time to expect the unexpected?
Adoption of Oral Disease Modifying Treatments to Manage Patients with Relapsing Remitting Multiple Sclerosis from 2011-2013 in the United States.
The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis.
Prescribed psychiatric medication among multiple sclerosis patients before and after disability pension: a register study with matched controls.
Setting a research agenda for progressive multiple sclerosis: The International Collaborative on Progressive MS.
Long-term effects of delayed-release dimethyl fumarate in multiple sclerosis: Interim analysis of ENDORSE, a randomized extension study.

Pages